Search Results 551-560 of 16636 for mushrooms

  1. A Study Comparing Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients with Non-valve Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention - Mayo Clinic

    A Study Comparing Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients with Non-valve Atrial ...

  2. A Registry Called Every Child for Collecting Data and Biology Specimens on Younger Patients with Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Faculty - Center for Regenerative Biotherapeutics - Mayo Clinic Research

    Faculty members from Mayo Clinic Center for Regenerative Biotherapeutics develop regenerative therapies to rebuild health from within patients' own bodies.

  4. MiCaP Research Digest - Mayo Clinic

    The goal is to create educational programming that helps black men make informed decisions about their prostate healthcare since they are diagnosed with ...

  5. Funding - Regenerative Neurobiology Lab - Mayo Clinic Research

    Anthony J. Windebank, M.D., principal investigator, A comprehensive combinatorial approach: modulation of the spinal cord microenvironment to induce ...

  6. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  7. Alumni - Cellular and Molecular Physiology of Gastrointestinal Disorders Laboratory - Mayo Clinic Research

    Alumni of the Cellular and Molecular Physiology of Gastrointestinal Disorders Lab study gastrointestinal physiology at Mayo Clinic and around the world.

  8. Thomas C. Spelsberg, Ph.D. - Mayo Clinic Faculty Profiles

    D., is engaged in studies regarding the mechanism of action of estrogens, selective estrogen receptor modulators (SERMs), select growth factors, and ...

  9. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

  10. A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) - Mayo Clinic

    The purpose of this study is to assess the effectiveness and safety of STN1010904 ophthalmic suspension (0.03%, and 0.1 %), twice daily dosing, when compared to ...